| 000 | 00664cam a2200193 4500 | ||
|---|---|---|---|
| 001 | CN99463 | ||
| 008 | 120401t2017 xxu||||| |||| 00| 0 eng d | ||
| 022 | _a0732183X | ||
| 100 | _aB. Pégourie, G. Pernod | ||
| 240 | _aJournal of Clinical Oncology | ||
| 245 | _aEvaluation of an oral direct anti-Xa anticoagulant, apixaban, for the prevention of venous thromboembolism in patients with myeloma treated with IMiD* compounds: A pilot study (MYELAXAT). | ||
| 260 | _c2017 | ||
| 300 | _a8019-8019 | ||
| 500 | _aSerial | ||
| 500 | _a7158680 | ||
| 500 | _a35 | ||
| 500 | _ahttps://doi.org/10.1200/JCO.2017.35.15_suppl.8019 | ||
| 500 | _aDocument_7158680_42549.pdf | ||
| 999 |
_c72023 _d72023 |
||